Overview
Azadeh Namakydoust is a Hematologist and an Oncologist in Farmington, Connecticut. Dr. Namakydoust is highly rated in 16 conditions, according to our data. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma.
Her clinical research consists of co-authoring 13 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Yale University
Scott Gettinger is an Oncologist and a Hematologist in New Haven, Connecticut. Dr. Gettinger has been practicing medicine for over 26 years is highly rated in 16 conditions, according to our data. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), EGFR Positive Lung Cancer, and Gamma Knife Radiosurgery.
Yale University
Nikolai Podoltsev is a Hematologist and an Oncologist in New Haven, Connecticut. Dr. Podoltsev is highly rated in 32 conditions, according to our data. His top areas of expertise are Acute Myeloid Leukemia (AML), Polycythemia Vera, Myeloproliferative Neoplasms (MPN), Bone Marrow Aspiration, and Bone Marrow Transplant.
Yale University
Harriet Kluger is an Oncologist and a Hematologist in New Haven, Connecticut. Dr. Kluger is highly rated in 21 conditions, according to our data. Her top areas of expertise are Melanoma, Renal Cell Carcinoma (RCC), Merkel Cell Carcinoma, Metastatic Brain Tumor, and Nephrectomy.
Areas of Expertise
When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
To learn more about how MediFind determines the expertise levels, check out our expert tiers page.
- Distinguished
- ALK-Positive Non-Small Cell Lung Cancer
- EGFR Positive Lung Cancer
- Large-Cell Lung Carcinoma
- Lung Adenocarcinoma
- Lung Cancer
- Lymphofollicular Hyperplasia
- Experienced
- Adult Soft Tissue Sarcoma
- Alveolar Soft Part Sarcoma
- Ampullary Cancer
- Anemia
- Bladder Cancer
- Bone Tumor